Skip to main content
NCBI home page
Gut logoLink to Gut
. 1992 Mar;33(3):381–386. doi: 10.1136/gut.33.3.381

Optimum bile acid treatment for rapid gall stone dissolution.

R P Jazrawi 1, M G Pigozzi 1, G Galatola 1, A Lanzini 1, T C Northfield 1
PMCID: PMC1373833  PMID: 1568660

Abstract

To determine the optimum bile acid regimen for rapid gall stone dissolution, 48 gall stone patients were divided into four groups of 12 according to stone diameter and were randomly allocated to receive one of four treatment regimens: bedtime or mealtime chenodeoxycholic acid (CDCA, 12 mg/kg/day) and bedtime or mealtime ursodeoxycholic acid (UDCA, 12 mg/kg/day). An additional 10 patients treated with a combination of CDCA plus UDCA (each 6 mg/kg/day) at bedtime were matched with the 10 patients on bedtime CDCA and the 10 on bedtime UDCA. The gall stone dissolution rates at six and 12 months were determined by standardised oral cholecystography and expressed as the percentage reduction in the gall stone volume after treatment. The gall stone dissolution rate at six months was higher for UDCA than CDCA treatment (median 78% v 48%, p less than 0.01), and for bedtime than mealtime administration (69% v 39%, p less than 0.02). Both differences were greater for stones less than 8 mm diameter. The dissolution rate was faster for combination therapy than for CDCA alone at both six (82% v 36%, p less than 0.05) and 12 months (100% v 54%, p less than 0.05), but was not different from UDCA alone. We conclude that bile acid treatment should be confined to patients with small gall stones and that bedtime administration of combined UDCA and CDCA is likely to provide the most effective and safe combination.

Full text

PDF
381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachrach W. H., Hofmann A. F. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I. Dig Dis Sci. 1982 Aug;27(8):737–761. doi: 10.1007/BF01393771. [DOI] [PubMed] [Google Scholar]
  2. Barbara L., Roda E., Roda A., Sama C., Festi D., Mazzella G., Aldini R. The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid. Digestion. 1976;14(3):209–219. doi: 10.1159/000197933. [DOI] [PubMed] [Google Scholar]
  3. Bateson M. C., Bouchier I. A., Trash D. B., Maudgal D. P., Northfield T. C. Calcification of radiolucent gall stone during treatment with ursodeoxycholic acid. Br Med J (Clin Res Ed) 1981 Sep 5;283(6292):645–646. doi: 10.1136/bmj.283.6292.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bateson M. C., Hill A., Bouchier I. A. Analysis of response to ursodeoxycholic acid for gallstone dissolution. Digestion. 1980;20(5):358–364. doi: 10.1159/000198460. [DOI] [PubMed] [Google Scholar]
  5. Bell G. D., Whitney B., Dowling R. H. Gallstone dissolution in man using chenodeoxycholic acid. Lancet. 1972 Dec 9;2(7789):1213–1216. doi: 10.1016/s0140-6736(72)92266-0. [DOI] [PubMed] [Google Scholar]
  6. Danzinger R. G., Hofmann A. F., Schoenfield L. J., Thistle J. L. Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med. 1972 Jan 6;286(1):1–8. doi: 10.1056/NEJM197201062860101. [DOI] [PubMed] [Google Scholar]
  7. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Tokyo Cooperative Gallstone Study Group. Gastroenterology. 1980 Mar;78(3):542–548. [PubMed] [Google Scholar]
  8. Ellis W. R., Somerville K. W., Whitten B. H., Bell G. D. Pilot study of combination treatment for gall stones with medium dose chenodeoxycholic acid and a terpene preparation. Br Med J (Clin Res Ed) 1984 Jul 21;289(6438):153–156. doi: 10.1136/bmj.289.6438.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Erlinger S., Le Go A., Husson J. M., Fevery J. Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid. Hepatology. 1984 Mar-Apr;4(2):308–314. doi: 10.1002/hep.1840040222. [DOI] [PubMed] [Google Scholar]
  10. Fromm H., Eschler A., Töllner D., Canzler H., Schmidt F. W. Untersuchungen zur Gallensteinauflösung in vivo. Studien über den Effekt von Chenodesoxycholsäure auf Gallensteine, Lithogenität der Galle und Serumlipide beim Menschen. Dtsch Med Wochenschr. 1975 Aug 8;100(32):1619–1624. doi: 10.1055/s-0028-1106432. [DOI] [PubMed] [Google Scholar]
  11. Fromm H. Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid. Gastroenterology. 1984 Jul;87(1):229–233. [PubMed] [Google Scholar]
  12. Fromm H., Roat J. W., Gonzalez V., Sarva R. P., Farivar S. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study. Gastroenterology. 1983 Dec;85(6):1257–1264. [PubMed] [Google Scholar]
  13. Iser J. H., Dowling H., Mok H. Y., Bell G. D. Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy. N Engl J Med. 1975 Aug 21;293(8):378–383. doi: 10.1056/NEJM197508212930804. [DOI] [PubMed] [Google Scholar]
  14. Iser J. H., Sali A. Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use. Drugs. 1981 Feb;21(2):90–119. doi: 10.2165/00003495-198121020-00002. [DOI] [PubMed] [Google Scholar]
  15. Iwamura K. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution. Hepatogastroenterology. 1980 Feb;27(1):26–34. [PubMed] [Google Scholar]
  16. Kupfer R. M., Maudgal D. P., Northfield T. C. Gallstone dissolution rate during chenic acid therapy. Effect of bedtime administration plus low cholesterol diet. Dig Dis Sci. 1982 Nov;27(11):1025–1029. doi: 10.1007/BF01391750. [DOI] [PubMed] [Google Scholar]
  17. Kutz K., Schulte A. Effectiveness of ursodeoxycholic acid in gallstone therapy. Gastroenterology. 1977 Sep;73(3):632–633. [PubMed] [Google Scholar]
  18. Marks J. W., Baum R. A., Hanson R. F., Hersh T., Hightower N. C., Jr, Mekhjian H., Schaefer R. A., Soloway R. D., Thistle J. L., Thomas F. B. Additional chenodiol therapy after partial dissolution of gallstones with two years of treatment. Ann Intern Med. 1984 Mar;100(3):382–384. doi: 10.7326/0003-4819-100-3-382. [DOI] [PubMed] [Google Scholar]
  19. Maton P. N., Iser J. H., Reuben A., Saxton H. M., Murphy G. M., Dowling R. H. Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence. Medicine (Baltimore) 1982 Mar;61(2):86–97. doi: 10.1097/00005792-198203000-00003. [DOI] [PubMed] [Google Scholar]
  20. Maton P. N., Murphy G. M., Dowling R. H. Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action. Lancet. 1977 Dec 24;2(8052-8053):1297–1301. doi: 10.1016/s0140-6736(77)90358-0. [DOI] [PubMed] [Google Scholar]
  21. Maudgal D. P., Bird R., Northfield T. C. Optimal timing of doses of chenic acid in patients with gall stones. Br Med J. 1979 Apr 7;1(6168):922–923. doi: 10.1136/bmj.1.6168.922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Maudgal D. P., Kupfer R. M., Northfield T. C. Factors affecting gall-stone dissolution rate during chenic acid therapy. Gut. 1983 Jan;24(1):7–10. doi: 10.1136/gut.24.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Naeye R. L. Causes and consequences of placental growth retardation. JAMA. 1978 Mar 20;239(12):1145–1147. [PubMed] [Google Scholar]
  24. Nakagawa S., Makino I., Ishizaki T., Dohi I. Dissolution of cholesterol gallstones by ursodeoxycholic acid. Lancet. 1977 Aug 20;2(8034):367–369. doi: 10.1016/s0140-6736(77)90301-4. [DOI] [PubMed] [Google Scholar]
  25. Neligan P., Bateson M. C., Trash D. B., Ross P. E., Bouchier I. A. Ursodeoxycholic acid for the dissolution of radiolucent gall bladder stones. Digestion. 1983;28(4):225–233. doi: 10.1159/000198992. [DOI] [PubMed] [Google Scholar]
  26. Podda M., Zuin M., Battezzati P. M., Ghezzi C., de Fazio C., Dioguardi M. L. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone. Gastroenterology. 1989 Jan;96(1):222–229. doi: 10.1016/0016-5085(89)90784-1. [DOI] [PubMed] [Google Scholar]
  27. Polli E. E., Bianchi P. A., Conte D., Sironi L. Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial. Digestion. 1981;22(4):185–191. doi: 10.1159/000198643. [DOI] [PubMed] [Google Scholar]
  28. Roda E., Bazzoli F., Labate A. M., Mazzella G., Roda A., Sama C., Festi D., Aldini R., Taroni F., Barbara L. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study. Hepatology. 1982 Nov-Dec;2(6):804–810. doi: 10.1002/hep.1840020611. [DOI] [PubMed] [Google Scholar]
  29. Salen G., Colalillo A., Verga D., Bagan E., Tint G. S., Shefer S. Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans. Gastroenterology. 1980 Jun;78(6):1412–1418. [PubMed] [Google Scholar]
  30. Schoenfield L. J., Lachin J. M. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety. Ann Intern Med. 1981 Sep;95(3):257–282. doi: 10.7326/0003-4819-95-3-257. [DOI] [PubMed] [Google Scholar]
  31. Stiehl A., Raedsch R., Czygan P., Götz R., Männer C., Walker S., Kommerell B. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid. Gastroenterology. 1980 Dec;79(6):1192–1198. [PubMed] [Google Scholar]
  32. Sugata F., Shimizu M. [Retrospective studies on gallstone disappearance (author's transl)]. Nihon Shokakibyo Gakkai Zasshi. 1974 Jan;71(1):75–80. [PubMed] [Google Scholar]
  33. Tangedahl T., Carey W. D., Ferguson D. R., Forsythe S., Williams M., Paradis K., Hightower N. C. Drug and treatment efficacy of chenodeoxycholic acid in 97 patients with cholelithiasis and increased surgical risk. Dig Dis Sci. 1983 Jun;28(6):545–551. doi: 10.1007/BF01308157. [DOI] [PubMed] [Google Scholar]
  34. Tint G. S., Salen G., Colalillo A., Graber D., Verga D., Speck J., Shefer S. Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones. Ann Intern Med. 1982 Sep;97(3):351–356. doi: 10.7326/0003-4819-97-3-351. [DOI] [PubMed] [Google Scholar]
  35. Ward A., Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy. Drugs. 1984 Feb;27(2):95–131. doi: 10.2165/00003495-198427020-00001. [DOI] [PubMed] [Google Scholar]
  36. Whiting M. J., Bradley B. M., Hall J. C., Watts J. M. Comparison of a monitored dose with a standard dose of chenodeoxycholic acid for gallstone dissolution. Digestion. 1984;30(4):211–217. doi: 10.1159/000199110. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES